The XPOVIO brand, founded in 2015 (United States), from 5 sister brands and 2214 competing brands. XPOVIO is a brand of Karyopharm Therapeutics, listed on the stock exchange of New York. XPOVIO belongs to the Biotechnology business sector.

XPOVIO is a brand of Karyopharm Therapeutics (KPTI) Share price

Share price and profitability of the share Karyopharm Therapeutics (XPOVIO)

Buy Karyopharm Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 1.44

Portfolio valuation
Karyopharm Therapeutics (XPOVIO) over 5 years* USD 0.36

Stock market history Karyopharm Therapeutics (XPOVIO)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more